10,026 reports of this reaction
1.4% of all LEFLUNOMIDE reports
#17 most reported adverse reaction
SYNOVITIS is the #17 most commonly reported adverse reaction for LEFLUNOMIDE, manufactured by sanofi-aventis U.S. LLC. There are 10,026 FDA adverse event reports linking LEFLUNOMIDE to SYNOVITIS. This represents approximately 1.4% of all 696,911 adverse event reports for this drug.
Patients taking LEFLUNOMIDE who experience synovitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SYNOVITIS is a less commonly reported adverse event for LEFLUNOMIDE, but still significant enough to appear in the safety profile.
In addition to synovitis, the following adverse reactions have been reported for LEFLUNOMIDE:
The following drugs have also been linked to synovitis in FDA adverse event reports:
SYNOVITIS has been reported as an adverse event in 10,026 FDA reports for LEFLUNOMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SYNOVITIS accounts for approximately 1.4% of all adverse event reports for LEFLUNOMIDE, making it a notable side effect.
If you experience synovitis while taking LEFLUNOMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.